Most health insurance plans cover at least some forms of hormone therapy, but what’s covered depends heavily on the type of hormone treatment, your specific plan, and the reason it’s prescribed. Menopause-related hormone therapy, testosterone replacement for diagnosed deficiencies, and gender-affirming hormones each follow different coverage rules, and insurers treat them as distinct categories with separate requirements.
Menopause Hormone Therapy Coverage
Standard hormone therapy for menopause symptoms is widely covered by private insurance, Medicare, and most Medicaid programs. Estrogen pills, patches, sprays, gels, and vaginal rings are all FDA-approved delivery methods, and insurers typically cover them when a doctor deems treatment medically necessary for symptoms like hot flashes, night sweats, or vaginal dryness.
Under Medicare, these medications fall under Part D prescription drug plans. Coverage varies by plan, though, so you’ll want to check your plan’s formulary, the list of drugs it covers. Plans organize medications into cost tiers, and where your specific hormone therapy lands on that tier system determines your copay. Some plans also require prior authorization, meaning your plan must approve the prescription before you can fill it at the covered price.
One notable exception: hormone pellets implanted under the skin. No hormone pellets currently have FDA approval, which means most insurers won’t cover them. If you’re interested in pellet therapy, expect to pay entirely out of pocket. Sticking with FDA-approved pills, patches, or gels is the simplest path to coverage.
Gender-Affirming Hormone Therapy
Coverage for gender-affirming hormones (estrogen or testosterone prescribed as part of a gender transition) has expanded significantly over the past decade, but it remains inconsistent across states and plan types. Whether you’re covered depends on where you live, what type of insurance you have, and your insurer’s specific policies.
For Medicaid, coverage varies dramatically by state. Currently, 26 states plus Washington, D.C. have Medicaid policies that explicitly cover transgender-related health care. Ten states have unclear or no explicit policy. Eleven states explicitly exclude transgender-related care for all ages, and three additional states exclude it specifically for minors.
Private insurers and employer-sponsored plans increasingly cover gender-affirming hormones, but they typically require documentation. A prior authorization request might need to include a formal diagnosis of gender dysphoria, a mental health assessment from a qualified provider, and evidence that any coexisting medical or mental health conditions are reasonably well controlled. Some plans require that the diagnosing mental health professional be separate from the prescribing provider and hold specific credentials in transgender care. Plans may also require documentation of past treatments tried and their outcomes.
Kaiser Permanente’s criteria offer a representative example of what large insurers expect. Their policy requires persistent, well-documented gender incongruence and at least one letter from an experienced gender therapist following established clinical guidelines, dated within 12 months of referral. Hormones themselves are often covered before surgical procedures, and in fact, many insurers require 12 months of hormone therapy before approving related surgeries like breast augmentation or facial procedures.
Federal Protections
Section 1557 of the Affordable Care Act prohibits sex-based discrimination in health programs, and the provision has been interpreted to include protections for transgender individuals seeking care. However, the legal landscape is complicated. Multiple federal court rulings since 2019 have blocked, stayed, or modified enforcement of different versions of these rules, creating a patchwork of protections that varies by jurisdiction. In practice, this means the strength of your legal footing for challenging a coverage denial depends partly on where you live.
Testosterone Replacement for Low T
Testosterone replacement therapy for men with clinically low testosterone (hypogonadism) is covered by most plans, but insurers require lab-confirmed evidence of a deficiency before they’ll approve it. The standard threshold at major insurers like UnitedHealthcare is two separate early-morning blood draws showing total testosterone below 300 ng/dL. Both tests must be done on different days, because testosterone levels fluctuate naturally.
Insurers make exceptions to the two-test requirement for certain conditions that are known to cause low testosterone, including genetic disorders like Klinefelter’s syndrome, surgical removal of both testes, or pituitary gland failure. If you have a documented history of one of these conditions, a single test or even medical records alone may be enough.
If your levels are borderline or your doctor suspects low T but your numbers don’t clearly meet the threshold, getting coverage becomes harder. Insurers are strict about that 300 ng/dL cutoff, and appeals without clear lab evidence below it rarely succeed.
Growth Hormone Therapy
Growth hormone replacement for adults is one of the more difficult hormone therapies to get covered. Insurers require rigorous proof of a true deficiency, not just low energy or age-related changes. Blue Cross Blue Shield of Massachusetts, for example, requires abnormal results on two separate stimulation tests, which are specialized lab procedures where a substance is given to provoke growth hormone release so doctors can measure the response. Patients with known pituitary damage, a history of brain radiation, or certain genetic conditions can qualify with just one abnormal test. Those with complete pituitary failure may qualify based on a low IGF-1 level (a blood marker that reflects growth hormone activity) without stimulation testing.
Because these medications are expensive and the testing requirements are extensive, prior authorization is virtually always required. Expect the approval process to take longer than it would for other hormone therapies.
What You’ll Pay Without Insurance
If you’re uninsured or your plan doesn’t cover your specific therapy, costs vary widely by medication type. Using pharmacy discount coupons, here’s what to expect per month:
- Estradiol tablets: roughly $10 to $35
- Estradiol patches: at least $45 at a typical dose
- Injectable testosterone cypionate: about $15 to $30
- Injectable testosterone enanthate: about $35 to $50
These are coupon prices through services like GoodRx, not retail pharmacy prices, which can be significantly higher. Injectable testosterone and oral estrogen are among the most affordable hormone medications available, even without insurance. Patches, gels, and brand-name formulations cost more.
How to Improve Your Chances of Coverage
Regardless of the type of hormone therapy, a few practical steps can make the difference between approval and denial. First, check your plan’s formulary before your doctor writes the prescription. If a cheaper generic or a preferred-tier medication treats your condition equally well, starting there avoids unnecessary hurdles. Second, make sure your lab work is thorough and recent. Insurers deny claims most often when documentation is incomplete, not because the treatment itself is excluded.
If your claim is denied, request the specific reason in writing. Many denials stem from missing paperwork rather than a policy exclusion, and resubmitting with complete documentation often resolves the issue. For gender-affirming care specifically, getting your mental health assessment and provider letters organized before submitting the authorization request saves weeks of back-and-forth. Your prescribing provider’s office typically handles the prior authorization process, but you can ask them what documentation has been submitted and follow up if the timeline stretches beyond a few weeks.